A01K 2267/0387
Animal model for diseases of the immune system
A01K2267/0387 (Animal model for diseases of the immune system) appears on 192 US grants and 325 published applications in this corpus.
Search patents in A01K- Granted patents
- 192
- Published applications
- 325
- Assignees
- 165
- Inventors
- 493
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 1 |
| 2003 | 2 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 5 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 3 |
| 2009 | 0 | 3 |
| 2010 | 3 | 11 |
| 2011 | 3 | 14 |
| 2012 | 3 | 16 |
| 2013 | 6 | 11 |
| 2014 | 10 | 11 |
| 2015 | 14 | 28 |
| 2016 | 12 | 25 |
| 2017 | 16 | 19 |
| 2018 | 12 | 20 |
| 2019 | 18 | 25 |
| 2020 | 10 | 24 |
| 2021 | 20 | 26 |
| 2022 | 10 | 27 |
| 2023 | 10 | 12 |
| 2024 | 13 | 18 |
| 2025 | 12 | 15 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Non-HLA matched humanized NSG mouse model with patient-derived xenograft7 Apr 2026US 12,595,490 B2The Jackson Laboratory
- Genetically modified T cell receptor mice24 Mar 2026US 12,582,105 B2Regeneron Pharmaceuticals, Inc.
- Non-HLA matched humanized NSG mouse model with patient-derived xenograft17 Mar 2026US 12,577,584 B2The Jackson Laboratory
- Mouse having a humanized b-cell activating factor gene3 Feb 2026US 12,538,905 B2Regeneron Pharmaceuticals, Inc.
- Optimised rag1 deficient gene therapy13 Aug 2026US 2026/0232842 A1
- Non-hla matched humanized nsg mouse model with patient-derived xenograft2 Jul 2026US 2026/0185119 A1The Jackson Laboratory
- Genetically modified t cell receptor mice4 Jun 2026US 2026/0150821 A1Regeneron Pharmaceuticals, Inc.
- Immune Cell-Engrafted Non-Human Animals and Non-Human Animal Models28 May 2026US 2026/0144239 A1Lapix Therapeutics, Inc.
- Genetically Modified Mice and Engraftment5 Mar 2026US 2026/0060222 A1Institute for Research in Biomedicine (IRB)
Most cited
By later US patents
- Compositions and methods for the treatment and diagnosis of immune disorders111US 6,562,343 B1Millennium Pharmaceuticals, Inc. · 2003
- Compositions and methods for the treatment and diagnosis of immune disorders106US 6,414,117 B1Millennium Pharmaceuticals, Inc. · 2002
- Compositions and methods for the treatment and diagnosis of immune disorders65US 6,204,371 B1Millennium Pharmaceuticals, Inc. · 2001
- Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome62US 5,981,175 AGenpharm Internation, Inc. · 1999
- Compositions and methods for the treatment and diagnosis of immune disorders57US 6,288,218 B12001